We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
Turnover
53.18%
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
+4.92%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$63.3M
AUM Growth
-$14.8M
(-19%)
Cap. Flow
-$16.4M
Cap. Flow
% of AUM
-25.83%
Top 10 Holdings %
Top 10 Hldgs %
48.64%
Holding
220
New
43
Increased
26
Reduced
21
Closed
74
Avg Time Held Equity + Options
1
year
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.3
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STOR
STORE Capital Corporation
STOR
|
+$998K |
| 2 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$667K |
| 3 |
ATCO
Atlas Corp.
ATCO
|
+$615K |
| 4 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$563K |
| 5 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
+$1.95M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.46M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.44M |
| 4 |
BRG
Bluerock Residential Growth REIT, Inc.
BRG
|
+$1.28M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$1.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.35% |
| 2 | Healthcare | 22.54% |
| 3 | Financials | 15.7% |
| 4 | Technology | 7.89% |
| 5 | Industrials | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Novavax
NVAX
$1.84B
| $181K | 0.29% |
+17,632
| New | +$311K |
2022 Q4
0 quarters
|
|
|
USER
77
DELISTED
UserTesting, Inc.
USER
| $180K | 0.28% |
+24,000
| New | +$154K |
2022 Q4
0 quarters
|
|
78
Cinemark Holdings
CNK
$4.47B
| $171K | 0.27% |
+19,713
| New | +$222K |
2022 Q4
0 quarters
|
|
79
Mustang Bio
MBIO
$2.84M
| $155K | 0.24% |
524
-79
| -13% | -$27K |
2021 Q3
5 quarters
|
|
80
The Gap Inc
GAP
$8.11B
| $153K | 0.24% |
+13,593
| New | +$163K |
2022 Q4
0 quarters
|
|
81
DELISTED
Future Health ESG Corp. Common stock
FHLT
| $148K | 0.23% |
14,632
| – | – |
2021 Q4
4 quarters
|
|
|
TCON
82
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $145K | 0.23% |
4,850
| – | – |
2021 Q2
6 quarters
|
|
83
Applovin
APP
$89B
| $139K | 0.22% |
+13,210
| New | +$194K |
2022 Q4
0 quarters
|
|
84
BlackRock Technology and Private Equity Term Trust
BTX
$990M
| $136K | 0.21% |
19,900
+6,900
| +53% | +$49.2K |
2022 Q3
1 quarter
|
|
85
DELISTED
DigitalBridge
DBRG
| $133K | 0.21% |
+12,161
| New | +$158K |
2022 Q4
0 quarters
|
|
86
Peloton Interactive
PTON
$2.29B
| $130K | 0.21% |
+16,366
| New | +$157K |
2022 Q4
0 quarters
|
|
87
Ecopetrol
EC
$36.9B
| $118K | 0.19% |
+11,254
| New | +$110K |
2022 Q4
0 quarters
|
|
|
ACOR
88
DELISTED
Acorda Therapeutics
ACOR
| $102K | 0.16% |
+6,625
| New | +$77.2K |
2022 Q4
0 quarters
|
|
|
FRTX
89
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $95K | 0.15% |
65,000
-1,000
| -2% | -$1.77K |
2020 Q4
8 quarters
|
|
90
Verastem
VSTM
$798M
| $91K | 0.14% |
18,750
+3,125
| +20% | +$15.3K |
2022 Q1
3 quarters
|
|
91
DELISTED
KORE Group Holdings
KORE
| $82K | 0.13% |
13,000
+2,200
| +20% | +$25.3K |
2021 Q4
4 quarters
|
|
92
United Microelectronic
UMC
$49.9B
| $81K | 0.13% |
+12,330
| New | +$81.7K |
2022 Q4
0 quarters
|
|
|
AGFS
93
DELISTED
AgroFresh Solutions Inc
AGFS
| $75K | 0.12% |
+25,201
| New | +$63.2K |
2022 Q4
0 quarters
|
|
|
ELVT
94
DELISTED
Elevate Credit, Inc.
ELVT
| $69K | 0.11% |
+39,373
| New | +$54.7K |
2022 Q4
0 quarters
|
|
95
Evaxion A/S
EVAX
$25.4M
| $68K | 0.11% |
750
+170
| +29% | +$19.9K |
2021 Q1
7 quarters
|
|
|
HARP
96
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $67K | 0.11% |
+9,300
| New | +$78.3K |
2022 Q4
0 quarters
|
|
|
APTO
97
DELISTED
Aptose Biosciences, Inc.
APTO
| $58K | 0.09% |
+222
| New | +$59.6K |
2022 Q4
0 quarters
|
|
|
HGEN
98
DELISTED
HUMANIGEN, INC.
HGEN
| $56K | 0.09% |
470,000
-30,000
| -6% | -$4.33K |
2020 Q3
9 quarters
|
|
99
Allot
ALLT
$441M
| $53K | 0.08% |
15,500
| – | – |
2021 Q4
4 quarters
|
|
100
DELISTED
Checkpoint Therapeutics
CKPT
| $51K | 0.08% |
+10,000
| New | +$72K |
2022 Q4
0 quarters
|
|
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q4 2022 Portfolio in Review
As of Q4 2022, Telemetry Investments held 220 positions worth $63.3M, down 19% from $78M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Telemetry Investments withdrew a net $16.4M in Q4 2022, closing 74 positions and reducing 21 holdings. Its most notable exit was Shell Midstream Partners, L.P., an estimated $1.95M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Telemetry Investments opened a new position in STORE Capital Corporation worth $1.01M.
- Telemetry Investments's largest Q4 2022 buy was STORE Capital Corporation: 31,461 shares worth $1.01M.
- Telemetry Investments added most to Eiger BioPharmaceuticals, Inc. in Q4 2022, an estimated $667K increase.
- Telemetry Investments's biggest Q4 2022 reduction was Freeport-McMoran, cutting an estimated $783K.
- Telemetry Investments fully exited Shell Midstream Partners, L.P. in Q4 2022, selling an estimated $1.95M.
- Telemetry Investments's ten largest holdings make up 49% of its $63.3M portfolio in Q4 2022.
- Telemetry Investments opened 43 new positions and closed 74 in Q4 2022.
- Telemetry Investments's portfolio value fell 19% quarter-over-quarter to $63.3M.
Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.